Lupus: Key pathogenic mechanisms and contributing factors

Clinical Immunology and Immunopathology

Volumn 77, Issue 3, 1995, Pages 209-220

  Mohan, Chandra ^a   Datta, Syamal K ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; NUCLEOSOME; PRIORITY JOURNAL; REVIEW;

ANIMAL; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE COOPERATION; MICE; NUCLEOSOMES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0028858002     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1995.1146     Document Type: Review

References (198)

1. Vlahakos, D. V., Foster, M. H., Adams, S., Ucci, A. A., Barrett, K. J., Datta, S. K., and Madio, M. P., Monoclonal anti-DNA antibodies derived from lupus-prone mice form immune deposits at distinct glomerular locations and induce different structural and functional abnormalities in vivo. Kidney Int. 41, 1690-1700, 1992.
2. Reeves, W. H., Satoh, M., Wang, J., Chou, C. H., and Ajmani, A. K., Systemic lupus erythematosus. Antibodies to DNA., DNA-binding proteins, and histones. Rheum. Dis. Clin. 20(1), 1-28, 1994.
3. Dang, H., and Harbeck, R. J., The in vivo and in vitro glomerular deposition of isolated anti-double-stranded DNA antibodies in NZB/W mice. Clin. Immunol. Immunopathol. 30, 265-278, 1984.
4. Brinkman, K., Termaat, R. M., Been, J. H. M., and Smeenk, R. J. T., Anti-DNA antibodies and lupus nephritis: Complexity of cross reactivity. Immunol. Today 11, 232-234, 1990.
5. Termaat, R. M., Assmann, K. J. M., Dijkman, H. B. P. M., van Gompel, F., Smeenk, R. J. T., and Berden, J. H. M., Anti-DNA antibodies can bind to glomerulus via two distinct mechanisms. Kidney Int. 42, 1363-1371, 1992.
6. Madaio, M. P., Carlson, J., Cataldo, J., Ucci, A., Migliorini, P., and Pankewycz, O., Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J. Immunol. 138, 2883-2889, 1987.
7. Faaber, P., Rijke, T. P. M., van de Putte, L. B. A., Capei, P. J. A., and Berden, J. H. M., Cross-reactivity of human and murine anti-DNA antibodies with heparan sulphate, the major glycosaminoglycan in glomerulo basement membranes. J. Clin. Invest. 77, 1824-1830, 1986.
8. Kramers, C., Hylkema, M. N., van Bruggen, M. C. J., van de Lagemaat, R., Dijkman, H. B. P. M., Assmann, K. J. M., Smeenk, R. J. T., and Berden, J. H. M., Anti-nucleosome antibodies complexed to nucleosomal antigens show DNA reactivity and bind to rat glomerular basement membrane in vivo. J. Clin. Invest. 94, 568-577, 1994.
9. Morika, T., Woitas, R., Fujigaki, Y., Batsford, S. R., and Vogt, A., Histone mediates glomerular deposition of small size DNA anti-DNA complex. Kidney Int. 45(4), 991-997, 1994.
10. Emlen, W., and Burdick, G., Clearance and organ localization of small DNA anti-DNA immune complexes in mice. J. Immunol. 140, 1816-1822, 1988.
11. Bennett, R. M., Peller, J. S., and Merritt, M. J., Defective DNA-receptor function in systemic lupus erythematosus and related diseases: Evidence for an autoantibody influencing cell phsyiology. Lancet 1, 186-188, 1986.
12. Bennet, R. M., Kotzin, B. L., and Merritt, M. J., DNA receptor dysfunction in systemic lupus erythematosus and kindred disorders. J. Exp. Med. 166, 850-863, 1987.
13. Frank, M. M., Hamburger, M. I., Lawley, T. J., Kimberly, R. P., and Plotz, P. H., Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N. Engl. J. Med. 300, 518-523, 1979.
14. Salmon, J. E., Millard, S. S., Arnett, F. C., Ramsey-Goldman, R., Mc Kenzie, S., Reilly, A., and Kimberly, R. P., Fc? Rlla is a non-MHC heritable risk factor for SLE in African-Americans. Arthritis Rheum. 37(9), S167, 1994.
15. Taylor, R. P., Horgan, C., Buschbacher, R., Brunner, C.M., Tess, C. E., O’Brien, W. M., and Wanebo, H. J., Decreased complement mediated binding of antibody/3H-dsdna immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematological malignancies. Arthritis Rheum. 26, 736-744, 1983.
16. Wilson, J. G., and Fearon, D. T., Altered expression of complement receptors as a pathogenic factor in systemic lupus erythematosus. Arthritis Rheum. 27, 1321-1328, 1984.
17. Robey, F. A., Jones, K. D., and Steinberg, A. D., C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. J. Exp. Med. 161, 1344-1356, 1985.
18. Rynes, R. I., Inherited complement deficiency states and SLE. Clin. Rheum. Dis. 8, 29-47, 1982.
19. Christiansen, F. T., Zhang, W. J., Griffiths, M., Mallal, S.A., and Dawkins, R. L., Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J. Rheumatol. 18, 1350-1358, 1991.
20. Morgan, B. P., and Walport, M. J., Complement deficiency and disease. Immunol. Today 12, 301-306, 1991.
21. Hughes-Jones, N. C., and Gardner, B., The reaction between the complement subcomponent Clq, Ig G complexes and poly-anionic molecules. Immunology 34, 459-463, 1978.
22. Reapple, E., Hill, H. U., and Loos, M., Mode of interaction of different polyanions with the first (C1, CD), the second (C2) and the fourth (C4) components of complement. I. Effect on fluid phase CI and on CI bound to EA or EAC4. Immunocytochem-istry 13, 251-255, 1976.
23. Crary, G. S., Katz, A., Fish, A. J., Michael, A. F., and Butkowski, A. J., Role of a basement membrane glycoprotein in anti-tubular basement membrane nephritis. Kidney Int. 43, 140-146, 1993.
24. Golan, T. D., Dan, S., Haim, H., Varda, G., and Sol, K., Solar ultraviolet radiation induces enhanced accumulation of oxygen radicals in murine SLE-derived splenocytes in vitro. Lupus 3, 103-106, 1994.
25. Golan, T. D., Foltyn, V., and Roueff, A., Increased susceptibility to in vitro ultraviolet B radiation in fibroblasts and lymphocytes cultured from systemic lupus erythematosus patients. Clin. Immunol. Immunopathol. 58, 289-304, 1991.
26. Bruijn, J. A., Bergijk, E. C., De Heer, E., Fleuren, G. J., and Hoedemaeker, P. J., Induction and progression of experimental lupus nephritis: Exploration of a pathogenic pathway. Kidney Int. 41, 5-13, 1992.
27. Jacob, C. O., and Mc Devitt, H. O., Tumour necrosis factor-« in murine autoimmune "lupus" nephritis. Nature 331, 356-358, 1988.
28. Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., and Mc Devitt, H. O., Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor a: Relevance to genetic predisposition to systemic lupus erythematosus. Proc. Nati. Acad. Sci. USA 87, 1233-1237, 1990.
29. Mitamura, K., Kang, H., Tornita, Y., Hashimoto, H., Sawada, S., and Horie, T., Impaired tumour necrosis factor-a production and abnormal B cell response to TNF-a in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 85, 386-391, 1991.
30. Malave, I., Searles, R. P., Montano, J., and Williams, R. C., Production of tumour necrosis factor/cachectin by peripheral blood mononuclear cells in patients with systemic lupus erythe-matosus. Int. Arch. Allergy Appi Immunol. 89, 355-361, 1989.
31. Tornita, Y., Hasimoto, S., Yamagami, K., Sawada, S., and Horie, T., Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythe-matosus (SLE). Clin. Exp. Rheumatol. 11, 533-536, 1993.
32. Boswell, J. M., Yui, M. A., Burt, D. W., and Kelly, V. E., Increased tumor necrosis factor and IL-lβ gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 141, 3050-3054, 1988.
33. Moutsopoulos, H. M., Boehm-Truitt, M., Kassan, S. S., and Chused, T. M., Demonstration of activation of B lymphocytes in NZB mice at birth by an immunoradiometric assay for murine Ig M. J. Immunol. 119, 1639-1644, 1977.
34. Klinman, D. M., and Steinberg, A. D., Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165, 1755-1760, 1987.
35. Cohen, P. L., and Ziff, M., Abnormal polyclonal B cell activation in NZB/NZW Fl mice. J. Immunol. 119, 1534-1537, 1977.
36. Izui, S., Mc Conahey, P. J., and Dixon, F. J., Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol. 121, 2213-2219, 1978.
37. Klinman, D. M., Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J. Clin. Invest. 86, 1249-1254, 1990.
38. Fauci, A. S., and Moutsopoulos, H. M., Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and Sjogren’s syndrome. Arthritis Rheum. 24(4), 577-583, 1981.
39. Sakane, T., Suzuki, N., Takada, S., Ueda, Y., Murakawa, Y., Tsuchida, T., Yamauchi, Y., and Kishimoto, T., B cell hyperac-tivity and its relation to distinct features and the degree of disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 31(1), 80-87, 1988.
40. Datta, S. K., Owen, F. L., Womack, J. E., and Riblet, R. J., Analysis of recombinant inbred lines derived from autoimmune NZB and high-leukemia (c58) strains: independent multigenic systems control B cell hyperactivity, retrovirus expression and autoimmunity. J. Immunol. 129, 1539-1544, 1982.
41. Perkins, D. L., Glaser, R. N., Mahon, C. A., Michaelson, J., and Marshak-Rothstein, A., Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 142, 549-555, 1990.
42. Sobel, E. S., Katagiri, T., Katagiri, K., Morris, S. C., Cohen, P. L., and Eisenberg, R. A., An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173, 1441-1449, 1991.
43. Nemazee, D., Guiet, C., Buerki, K., and Marshak-Rothstein, A., B lymphocytes from the autoimmune prone mouse strain MRIV lpr manifest an intrinsic defect in tetraparental MRL/lpr-DBA/2 chimeras. J. Immunol. 147, 2536-2539, 1991.
44. Merino, R., Fossati, L., Lacour, M., and Izui, S., Selective autoantibody production by Yaa+ B cells in autoimmune Yaa+Yaabone marrow chimeric mice. J. Exp. Med. 174, 1023-1029, 1991.
45. Reininger, L., Radaszkiewicz, T., Kosco, M., Melchers, F., and Rolink, A. G., Development of autoimmune disease in SCID mice populated with long-term "in-vitro" proliferating (NZB x NZW) Fl pre-B cells. J. Exp. Med. 176, 1343-1353, 1992.
46. Manohar, V., Brown, E., Leiserson, W. M., and Chused, T. M., Expression of Lyt-1 by a subset of B-lymphocytes. J. Immunol. 129, 532-538, 1982.
47. Hayakawa, K., Hardy, R. R., Honda, M., Herzenberg, L. A., Steinberg, A. D., and Herzenberg, L. A., Ly-1 B-cells: Functionally distinct lymphocytes that secrete Ig M autoantibodies. Proc. Nati. Acad. Sci. USA 81, 2494-2498, 1984.
48. Shan, H., Shlomchik, M. J., Marshak-Rothstein, A., Pisetsky, D. S., Litwin, S., and Weigert, M., The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153, 5104-5120, 1994.
49. Burlingame, R. W., Rubin, R. L., Balderas, R. S., and Theofilopoulos, A. N., Genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self-antigen. J. Clin. Invest. 91, 1687-1696, 1993.
50. Burlingame, R. W., Boey, M. L., Starkebaum, G., and Rubin, R. L., The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest 94, 184-192, 1994.
51. Marion, T. N., Tillman, D. M., Jou, N. T., and Hill, R. J., Selection of immunoglobulin variable regions in autoimmunity to DNA. Immunol. Rev. 128, 123-149, 1992.
52. Klinman, D. M., Shirai, A., Ishigatsubo, Y., Conover, J., and Steinberg, A. D., Quantitation of Ig M- and Ig G-secreting B-cells in the peripheral blood of patients with systemic lupus erythematosus. Arthritis Rheum. 34, 1404-1410, 1991.
53. Hirose, S., Wakiya, M., Kawano-Nishi, Y., Yi, J., Sanokawa, R., Taki, S., Shimamura, T., Kishimoto, T., Tsurui, H., Nishimura, H., and Shirai, T., Somatic diversification and affinity maturation of Ig M., and Ig G anti-DNA antibodies in murine lupus. Eur. J. Immunol. 23, 2813-2820, 1993.
54. Tillman, D. M., Jou, N. T., Hill, R. J., and Marion, T. N., Both Ig M and Ig G anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW) Fl mice. J. Exp. Med. 176, 761-779, 1992.
55. Eastcott, J. W., Schwartz, R. S., and Datta, S. K., Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB x SWR crosses. J. Immunol. 131, 2232-2239, 1983.
56. Shefner, R., Kleiner, G., Türken, A., Papazian, L., and Diamond, B., A novel class of anti-DNA antibodies identified in BALB/c mice. J. Exp. Med. 173, 287-296, 1991.
57. Gleichmann, E., van Elven, E. H., and van der Veen, J. P. W., A systemic lupus erythematosus (SLE) like disease induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12, 152-159, 1982.
58. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S., Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apop-tosis. Nature 356, 314-317, 1992.
59. Itoh N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S., The poly-peptide encoded by the CDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243, 1991.
60. Reap, E. A., Leslie, D., Abrahams, M., Eisenberg, R. A., and Cohen, P. L., Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154, 936-943, 1995.
61. Roark, J. H., Kuntz, C. L., Nguyen, K-A., Caton, A. J., and Erikson, J., Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181, 1157-1167, 1995.
62. Rathmell, J. C., and Goodnow, C. C., Effects of the lpr mutation on elimination and inactivation of self-reactive B-cells. J. Immunol. 153, 2831-2842, 1994.
63. Izui, S., Kelly, V. E., Masuda, K., Yoshida, H., Roths, J. B., and Murphy, E. D., Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133, 227-233, 1984.
64. Kelly, V. E., and Roths, J. B., Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37, 220-229, 1985.
65. Sercarz, E. E., and Datta, S. K., Mechanisms of autoimmunization: Perspective from the mid-90s. Curr. Opin. Immunol. 6, 875-881, 1994.
66. Cyster, J. G., Hartley, S. B., and Goodnow, C. C., Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371, 389-395, 1994.
67. Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., and Harris, A. W., Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and exhibits autoimmune disease. Proc. Nati. Acad. Sci. USA 88, 8661-8665, 1991.
68. Nisitani, S., Tsubata, T., Murakami, M., Okamoto, M., and Honjo, T., The bcl-2 gene product inhibits clonai deletion of self-reactive B lymphocytes in the periphery but not in the bone-marrow. J. Exp. Med. 178, 1247-1254, 1993.
69. Ohsako, S., Hara, M., Harigai, M., Fukasawa, C., and Kashiwazaki, S., Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunopathol. 73, 109-114, 1994.
70. Aringer, M., Wintersberger, W., Steiner, C. W., Kiener, H., Presterl, E., Jaeger, U., Smolen, J. S., and Graninger, W. B., High levels of bcl-2 protein in circulating T lymphocytes but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum. 37, 1423-1430, 1994.
71. Shultz, L. D., and Green, M. C., Motheaten, an immunodefi-cient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J. Immunol. 116, 936-943, 1976.
72. Shultz, L. D., Coman, D. R., Bailey, C. L., Beamer, W. G., and Sidman, C. L., "Viable motheaten," a new allele at the moth-eaten locus. I. Pathology. Am. J. Pathol. 116, 179-192, 1984.
73. Bignon, J. S., and Siminovitch, K. A., Identification of PTP1C mutation as the genetic defect in Motheaten and viable Moth-eaten mice: A step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. Immunopathol. 73, 168-179, 1994.
74. Cyster, J. G., and Goodnow, C. C., Protein tyrosine phos-phatase 1C negatively regulates receptor signaling in B lymphocytes and determines threshold for negative selection. Immunity 2, 13-24, 1995.
75. D’Ambrosio, D., Hippen, K. L., Minskoff, S.A., Mellman, I., Pani, G., Siminovitch, K. A., and Cambier, J. C., Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc RUBI. Science 268, 293-296, 1995.
76. Pani, G., Kozlowski, M., Cambier, J. C., Mills, G. B., and Siminovitch, K. A., Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181, 2077-2084, 1995.
77. Linker-Israeli, M., Cytokine abnormalities in human lupus. Clin. Immunol. Immunopathol. 63, 10-12, 1992.
78. Kitani, A., Hara, M., Hirose, T., Harigai, K., Suzuki, M., Kawakami, Y., Kawaguchi, T., Hidaka, M., Kawagoe, M., and Nakamura, H., Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: Analysis of interleukin-6 production and IL-6 expression. Clin. Exp. Immunol. 88, 75-83, 1992.
79. Spronk, P. E., Ter Borg, E. J., Limburg, P. C., and Kallenberg, C. G. M., Plasma concentration of interleukin-6 in systemic lupus erythematosus: An indicator of disease activity? Clin. Exp. Immunol. 90, 106-110, 1992.
80. Nagafuchi, H., Suzuki, N., Mizushima, Y., and Sakane, T., Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151, 6525-6534, 1993.
81. Linker-Israeli, M., Prehn, J., Wallace, D. J., Li, L., and Klinenberg, J. R., Study of an IL-6 gene XBAI restriction fragment associated with systemic lupus erythematosus (SLE). Arthritis Rheum. 36, S111, 1994. [Abstract]
82. Bell, D. A., Morrison, B., and Vanden Bygaart, P., Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85, 1487-1496, 1990.
83. Guerne, P-A., Carson, D. A., and Lotz, M., IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol. 144, 499-505, 1990.
84. Llorente, L., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Maillot, M. C., Durand-Gasselin, B., Fourrier, B. M., Galanaud, P., and Emilie, D., Spontaneous production of inter-leukin-10 by B-lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Network 4, 421-427, 1993.
85. Llorente, L., Richaud-Patin, Y., Fior, R., Alcocer-Varela, J., Wijdenes, J., Fourrier, B. M., Galanaud, P., and Emilie, D., In vivo production of interieukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. Arthritis Rheum. 37, 1647-1655, 1994.
86. Ishida, H., Hastings, R., Kearney, J., and Howard, M., Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175, 1213-1220, 1992.
87. Llorente, L., Zou, W., Levy, Y., Richard-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Morel-Fourrier, B., Brouet, J-C., Alarcon-Segovia, D., Galanaud, P., and Emilie, D., Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181, 839-844, 1995.
88. Ishida, H., Muchamuel, T., Sakaguchi, S., Andradre, S., Menon, S., and Howard, M., Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W Fl mice. J. Exp. Med. 179, 305-310, 1994.
89. Gangemi, R. M., Singh, A. K., and Barrett, K. J., Independently derived Ig G anti-DNA autoantibodies from two lupus-prone mouse strains express a VH gene that is not present in most murine strains. J. Immunol. 151, 4660-4671, 1993.
90. Harada, T., Suzuki, N., Mizushima, Y., and Sakane, T., Usage of a novel class of germline Ig variable region gene for cationic anti-DNA autoantibodies in human lupus nephritis and its role for the development of the disease. J. Immunol. 153, 4806-4815, 1994.
91. Diamond, B., Katz, J. B., Paul, E., Aranow, C., Lustgarten, D., and Scharff., The role of somatic mutation in the pathogenic anti-DNA response. Annu. Rev. Immunol. 10, 731-757, 1992.
92. Drake, C. G., Babcock, S. K., Palmer, E., and Kotzin, B. L., Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW) Fl mice. Proc. Nati. Acad. Sci. USA 91, 4062-4066, 1994.
93. Drake, C. G., Rozzo, S. J., Hirschfeld, H. F., Smamworawong, N. P., Palmer, E., and Kotzin, B. L., Analysis of the New Zealand Black contribution to lupus-like renal disease. J. Immunol. 154, 2441-2447, 1995.
94. Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., and Wakeland, E. K., Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1, 219-229, 1994.
95. Kono, D. H., Burlingame, R. W., Owens, D. G., Kuramochi, A., Balderas, R. S., Balomenos, D., and Theofilopoulos, A. N., Lupus susceptibility loci in New Zealand mice. Proc. Nati. Acad. Sci. USA 91, 10168-10172, 1994.
96. Bias, W. B., Reveille, J. D., Beaty, T. L. H., Meyers, D. A., and Arnett, F. C., Evidence that autoimmunity in man is a Mende-Han dominant trait. Am. J. Hum. Genet. 39, 584-602, 1986.
97. Steinberg, A. D., Roths, J. B., Murphy, E. D., Steinberg, R. T., and Raveche, E. S., Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol. 125, 871-873, 1980.
98. Mihara, M., Ohsugi, Y., Saito, K., Miyai, T., Togashi, M., Ono, S., Murakami, S., Dobashi, K., Hirayama, F., and Hamaoka, T., Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of athymic nude individuals. J. Immunol. 141, 85-90, 1988.
99. Wofsy, D., and Seamen, W. E., Reversal of advanced murine lupus in NZB/NZW Fl mice by treatment with monoclonal antibody to L3T4. J. Immunol. 138, 3247-3253, 1987.
100. Datta, S. K., Patel, H., and Berry, D., Induction of a cationic shift in Ig G anti-DNA autoantibodies: Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165, 1252-1268, 1987.
101. Mohan, C., Shi, Y., Laman, J., and Datta, S. K., Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154, 1470-1480, 1995.
102. Ando, D. G., Sercarz, E. E., and Hahn, B. H., Mechanisms of T and B cell collaboration in the in-vitro production of anti-DNA antibodies in the NZB/NZW FI murine SLE model. J. Immunol. 138, 3185-3190, 1987.
103. bm12 mice. J. Immunol. 149, 4109-4115, 1992.
104. Sobel, E. S., Kakkanaiah, V. N., Kakkanaiah, M., Cheek, R. L., Cohen, P. L., and Eisenberg, R. A., T-B collaboration for au-toantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 152, 6011-6016, 1994.
105. Shivakumar, S., Tsokos, G. C., and Datta, S. K., T cell receptor aβ expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143, 103-112, 1989.
106. Murakami, M., Kumagai, S., Sugita, M., Iwai, K., and Imura, H., In-vitro induction of Ig G anti-DNA antibody from high-density B-cells of systemic lupus erythematosus patients by an HLA-DR restricted T cell clone. Clin. Exp. Immunol. 90, 245-250, 1992.
107. Theocharis, S., Sfikakis, P.P., Lipnick, R. N., Klipple, G. L., Steinberg, A. D., and Tsokos, G. C., Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin. Immunol. Immunopatkol. 74, 135-142, 1995.
108. Adams, S., Leblanc, P., and Datta, S. K., Junctional region sequences of T-cell receptor β-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T-cells from lupus mice: Possible selection by cationic autoantigens. Proc. Nati. Acad. Sci. USA 88, 11271-11275, 1991.
109. Mohan, C., Adams, S., Stannik, V., and Datta, S. K., Nucleo-some: A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177, 1367-1381, 1993.
110. Desai-Mehta, A., Mao, C., Rajagopalan, S., Robinson, T., and Datta, S. K., Structure and specificity of T-cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95, 531-541, 1995.
111. Singer, P. A., Balderas, R. S., Mc Evilly, R. J., Bobardt, M., and Theofilopoulos, A. N., Tolerance-related Vβ clonai deletions in normal CD4-8- TCR aβ+ and abnormal lpr and gld cell populations. J. Exp. Med. 170, 1869-1877, 1989.
112. Kotzin, B. L., Kappler, J. W., Marrack, P. C., and Herron, L. R., T cell tolerance to self antigens in New Zealand hybrid mice with lupus like disease. J. Immunol. 143, 89-94, 1989.
113. Herron, L. R., Eisenberg, R. A., Roper, E., Kakkaniah, V. N., Cohen, P. L., and Kotzin, B. L., Selection of the T cell receptor repertoire in lpr mice. J. Immunol. 151, 3450-3459, 1993.
114. Singer, G. G., and Abbas, A. K., The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371, 1994.
115. Russell, J. H., and Wang, R., Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 23, 2379-2382, 1993.
116. Zhou, T., Bluethmann, H., Zhang, J., Edwards, C. K., and Mountz, J. D., Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice. J. Exp. Med. 176, 1063-1072, 1992.
117. Bossu, P., Singer, G. G., Andres, P., Ettinger, R., Marshak-Rothstein, A., and Abbas, A. K., Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor mediated tolerance and apoptosis. -J. Immunol. 151, 7233-7239, 1993.
118. Scott, D. E., Kisch, W. S., and Steinberg, A. D., Studies of T-cell deletion and T-cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J. Immunol. 150, 664-672, 1993.
119. Flaegstad, T., Fredricksen, K., Dahl, B., Traavik, T., and Rekvig, O. P., Inoculation with BK virus may break immuno-logical tolerance to histones and DNA antigens. Proc. Nati. Acad. Sci. USA 85, 8171-8175, 1988.
120. Rekvig, O. P., Fredricksen, K., Brannsether, B., Moens, U., Sundsfjord, A., and Traavik, T., Antibodies to eukaryotic, including autologous, native DNA are produced during BK virus infection, but not after immunization with non-infectious BK DNA. Scand. J. Immunol. 36, 487-495, 1992.
121. Fredriksen, K., Osei, A., Sundsfjord, A., Traavik, T., and Rekvig, O. P., On the biological origin of anti-dsdna antibodies: Systemic lupus erythematosus related anti-dsdna antibodies are induced by polyoma BK in lupus-prone (NZB x NZW) Fl hybrids, but not in normal mice. Eur. J. Immunol. 24, 66-70, 1994.
122. James, J. A., Gross, T., Hal-Scofield, R., and Harley, J. B., Im-munoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B’ derived PPPGMRPP and PPP-GIRGP induce spliceosome autoimmunity. J. Exp. Med. 181, 453-461, 1995.
123. Casciola-Rosen, L. A., Anhalt, G., and Rosen, A., Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330, 1994.
124. Reichlin, M., Martin, A., Taylor-Albert, E., Tsuzaka, K., Zhang, W., Reichlin, M. W., Koren, E., Ebling, F. M., Tsao, B., and Hahn, B. H., Lupus autoantibodies to native DNA cross-react with the A and D Sn RNP polypeptides. J. Clin. Invest. 93, 443-449, 1994.
125. Bloom, D. D., Davignon, J-L., Cohen, P. L., Eisenberg, R. A., and Clarke, S. H., Overlap of the anti-Sm and anti-DNA response of MRL/Mp-lpr/lpr mice. J. Immunol. 150, 1579-1590, 1993.
126. Desai, D.D., Krishnan, M. R., Swindle, J. T., and Marion, T. N., Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J. Immunol. 151, 1614-1626, 1993.
127. Kanai, Y., Takeda, O., Kanai, Y., Miura, K., and Kurosawa, Y., Novel autoimmune phenomena induced in vivo by a new DNA binding protein Nuc: A study on MRL/n mice. Immunol. Lett. 39, 83-89, 1994.
128. Krieg, A. M., Yi, A-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinmati, D. M., Cp G motifs in bacterial DNA trigger direct B cell activation. Nature 374, 546-549, 1995.
129. Gilkeson, G. S., Pippen, A. M. M., and Pisetsky, D. S., Induction of cross-reactive anti-dsdna antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95, 1398-1402, 1995.
130. Batchelor, J. R., Systemic lupus erythematosus and genes within the HLA region. Br. J. Rheumatol. 32, 13-15, 1993.
131. Ghatak, S., Sainis, K., Owen, F. L., and Datta, S. K., T cell receptor β and I-Aβ chain genes of normal SWR mice are linked with development of lupus nephritis in NZB x SWR crosses. Proc. Nati. Acad. Sci. USA 84, 6850-6853, 1987.
132. Hirose, S., Ueda, G., Noguchi, K., Okada, T., Sekigawa, I., Sato, H., and Shirai, T., Requirement of H-2 heterozygosity for au-toimmunity in (NZB x NZW) Fl hybrid mice. Eur. J. Immunol. 16, 1631-1633, 1986.
133. Kotzin, B. L., and Palmer, E., The contribution of NZW genes to lupus-like disease in (NZB x NZW) Fl mice. J. Exp. Med. 167, 1237-1251, 1987.
134. Adelman, N. E., Watling, D. L., and Mc De Vitt, H. O., Treatment of (NZB x NZW) Fl disease with anti-I-A monoclonal antibodies. J. Exp. Med. 158, 1350-1355, 1983.
135. Cohen, P. L., Rapaport, R., and Eisenberg, R. A., Characterization of functional T-cell lines derived from MRL mice. Clin. Immunol. Immunopathol. 40, 485-496, 1986.
136. Portonova, J. P., Ebling, F. M., Hammond, W. S., Hahn, B. H., and Kotzin, B. L., Allogenic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease. J. Immunol. 141, 3370-3376, 1988.
137. Kawano, H., Abe, M., Zhang, D., Saikawa, T., Fujimori, M., Hirose, S., and Shirai, T., Heterozygosity of the major histo-compatibility complex controls the autoimmune disease in (NZW x BXSB) Fl mice. Clin. Immunol. Immunopathol. 65, 308-314, 1992.
138. Merino, R., Fossati, L., Lancour, M., Lemoine, R., Higaki, M., and Izui, S., H-2 linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22, 295-299, 1992.
139. Merino, R., Iwamoto, M., Gershwin, M. E., and Izui, S., The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB x BXSB) Fl hybrid mice. J. Clin. Invest. 94, 521-525, 1994.
140. bm12 to the production of autoantibodies to dsdna. Autoimmunity 11, 81-88, 1991.
141. Theofìlopoulos, A. N., Balderas, R. S., Baccalà, R., and Kono, D. H., T-cell receptor genes in autoimmunity. Ann. N.Y. Acad. Sci. 681, 33-46, 1993.
142. Davies, K. A., Erlendsson, K., Beynon, H. L. C., Peters, A. M., Steinsson, K., Valdimarsson, H., and Walport, M. J., Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151, 3866-3873, 1993.
143. Cascino, I., Galeazzi, M., Salvetti, M., Ristori, G., Morozzi, G., Momigliano, P., and Tosi, R., HSP70-1 promoter region polymorphism tested in three autoimmune diseases. Immunogenet-ics 39, 291-293, 1994.
144. Klinman, D. M., Shirai, A., Conover, J., and Steinberg, A. D., Cross-reactivity of Ig G anti-DNA secreting B cells in patients with systemic lupus erythematosus. Eur. J. Immunol. 24, 53-58, 1994.
145. Chu, E. B., Ernst, D. N., Hobbs, M. V., and Weigle, W. O., Mat-urational changes in CD4 cell subsets and lymphokine production in BXSB mice. J. Immunol. 152, 4129-4138, 1994.
146. Davidson, W. F., Calkins, C., Hugins, A., Giese, T., and Holmes, K. L., Cytokine secretion by C3H-lpr and gld T-cells. Hyperse-cretion of IFN-y and TNF-a by stimulated CD4+ T cells. J. Immunol. 146, 4138-4148, 1991.
147. Mosmann, T. R., and Coffman, R. L., TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173, 1989.
148. Gavalchin, J., and Datta, S. K., The NZB x SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a distinctive and restricted idiotypic diversity. J. Immunol. 138, 138-148, 1987.
149. Fisher, C. L., Eisenberg, R. A., and Cohen, P. L., Quantitäten and Ig G subclass distribution of antichromatin autoantibodies in SLE mice. Clin. Immunol. Immunopathol. 46, 205-213, 1988.
150. Theofìlopoulos, A. N., and Dixon, F. J., Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269-390, 1985.
151. Park, C. L., Balderas, R. S., Fieser, T. M., Slacks, J. H., Prudhomme, G. J., Dixon, F. J., and Theofìlopoulos, A. N., Isotypic profiles and other characteristics of immune responses to exogenous thymus-dependent and independent antigens by mice with lupus syndromes. J. Immunol. 130, 2161-2167, 1983.
152. Heremans, H.A., Billiau, A., Colombatti, A., Hilders, J., and de Somer, P., Interferon treatment of NZB mice: Accelerated progression of autoimmune disease. Infect. Immun. 21, 925-930, 1978.
153. Jacob, C. O., van der Meide, P. H., and Mc Devitt, H. O., In vivo treatment of (NZB x NZW) Fl lupus-like nephritis with monoclonal antibody to y-interferon. J. Exp. Med. 166, 798-803, 1987.
154. Sergiescu, D., Cerutti, I., Efthymiou, E., Kahan, A., and Chany, C., Adverse effects of interferon treatment on the life span of NZB mice. Biomed. Express 31, 48-51, 1979.
155. Ozmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B., and Garotta, G., Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-y receptor inhibits the onset of glomerulone-phritis. Eur. J. Immunol. 25, 6-12, 1995.
156. Wandl, U. B., Nagel-Hiemke, M., Kreuzfelder, E., Kloke, O., Kranzhoff, M., Seeber, S., and Niederle, N., Lupus-like autoimmune disease induced by interferon therapy for myeloprolifer-ative disorders. Clin. Immunol. Immunopathol. 65, 70-74, 1992.
157. Hsieh, C-S., Macatonia, S. E., O’garra, A., and Murphy, K. M., T-cell genetic background determines default T helper pheno-type development in-vitro. J. Exp. Med. 181, 713-721, 1995.
158. Morito, F., Hiida, M., Ohta, A., and Yamaguchi, M., Genetic analysis of systemic lupus erythematosus: Association with a T cell receptor restriction fragment length polymorphism in Japanese patients. Intern. Med. 31, 998-1003, 1992.
159. Tebib, J. G., Alcocer-Varela, J., Alarcon-Segovia, D., and Schur, P. H., Association between a T cell receptor restriction length polymorphism and systemic lupus erythematosus. J. Clin. Invest. 86, 1961-1967, 1990.
160. Adams, S., Zordan, T., Sainis, K., and Datta, S. K., T cell receptor Vβ genes expressed by Ig G anti-DNA autoantibody-inducing T cells in lupus nephritis: Forbidden receptors and double-negative cells. Eur. J. Immunol. 20, 1435-1443, 1990.
161. Theofìlopoulos, A. N., Balderas, R. S., Baccalà, R., and Kono, D. H., T-cell receptor genes in autoimmunity. Ann. N.Y. Acad. Sci. 681, 33-46, 1993.
162. Rozzo, S. J., Drake, C. G., Chiang, B-L., Gershwin, M. E., and Kotzin, B. L., Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J. Immunol. 153, 1340-1351, 1994.
163. Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E., and Hahn, B. H., T cell determinants from au-toantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181, 2017-2027, 1995.
164. Ebling, F. M., Tisao, R. R., Sercarz, E. E., and Hahn, B. H., A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW) Fl mouse model of systemic lupus erythematosus. Arthritis Rheum. 36, 355-364, 1993.
165. Sekigawa, L., Okada, T., Noguchi, K., Ueda, G., Hirose, S., Sato, H., and Shirai, T., Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW) Fl hybrid mice. J. Immunol. 138, 2890-2895, 1987.
166. Takeda, K., and Dennert, G., The development of autoimmunity in C57BL’6 tpr mice correlates with the disappearance of natural killer type 1 positive cells: Evidence for their suppres-sive action on bone-marrow stem cell proliferation, B cell im-munoglobulin secretion, and autoimmune symptoms. J. Exp. Med. III, 155-164, 1993.
167. Theofilopoulos, A.N., The basis of autoimmunity. I. Mechanisms of aberrant self-recognition. Immunol. Today 16(2), 90-98, 1995.
168. Linker-Israeli, M., Quismorio, F. P., and Horwitz, D. A., CD8+ lymphocytes from patients with systemic lupus erythematosus sustain rather than suppress spontaneous polyclonal Ig G production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum. 33(8), 1216-1225, 1990.
169. Stollar, B. D., Immunochemistry of DNA. Int. Rev. Immunol. 5, 1-22, 1989.
170. Pleiscia, O. J., Braun, W., and Palczuk, N. C., Production of antibodies to denatured deoxyribonucleic acid (DNA). Proc. Nati. Acad. Sci. USA 52, 279-283, 1964.
171. Stollar, B. D., Fuchs, S., and Mozes, E., Immune response of mice to nucleic acids: Strain-dependent differences in magnitude and class of antibody production. J. Immunol. 111, 121-129, 1973.
172. Madaio, M. P., Hodder, S., Schwartz, R. S., and Stollar, B. D., Responsiveness of autoimmune and normal mice to nucleic acid antigens. J. Immunol. 132, 872-876, 1984.
173. Monestier, M., and Kotzin, B. L., Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Clin. Rheum, bis. 18, 415-436, 1992.
174. Amoura, Z., Chabre, H., Koutouzov, S., Lotton, C., Cabrespines, A., Bach, J. F., and Jacob, L., Nucleosome restricted antibodies are detected before anti-dsdna in the sera of MRL-Mp lpr/lpr and +/+ mice and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37(11), 1684-1688, 1994.
175. Rumore, P., and Steinman, C. Exogenous circulating DNA in systemic lupus erythematosus. Occurrences as multimeric complexes bound to histones. J. Clin. Invest. 86, 69-74, 1990.
176. Fournie, G. J., Circulating DNA and lupus nephritis. Kidney Int. 33, 487-497, 1988.
177. Carson, D. A., The specificity of anti-DNA antibodies in systemic lupus erythematosus. J. Immunol. 146, 1-2, 1991.
178. Du Clos, T. W., Zlock, L. T., Hicks, P.S., and Mold, C., Decreased autoantibody levels and enhanced survival of (NZB x NZW) Fl mice treated with C-reactive protein. Clin. Immunol. Immunopathol. 70, 22-27, 1994.
179. Atkinson, M. J., Bell, D. A., and Singhal, S. K., A naturally occurring polyclonal B cell activator of normal and autoantibody responses. J. Immunol. 135, 2524-2533, 1985.
180. Hefeneider, S. H., Cornell, K. A., Brown, L. E., Bakke, A. C., Mc Coy, S. L., and Bennett, R. M., Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin. Immunol. Immunopathol. 63(3), 245-251, 1992.
181. Lambert, P. H., and Dixon, F. J., Pathogenesis of glomerular nephritis in NZB/W mice. J. Exp. Med. 127, 507-522, 1968.
182. Raptis, L., and Menard, H. A., Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J. Clin. Invest. 66, 1391-9, 1980.
183. McCourbrey-Hoyer, A., Okarma, T. B., and Holman, H. R., Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am. J. Med. 77, 23-34, 1984.
184. Steinman, C. R., Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J. Clin. Invest. 73, 832-841, 1984.
185. Fournie, G. J., Lambert, P. H., and Miescher, P. A., Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial polysaccharides. J. Exp. Med. 140, 1189-1206, 1974.
186. Rumore, P., Muralidhar, B., Lin, M., Lai, C., and Steinman, C. R., Hemodialysis as a model for studying enenous plasma DNA: Oligonucleosome-like structure and clearance. Clin. Exp. Immunol. 90, 56-62, 1992.
187. Van Houten, N., and Budd, R. C., Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J. Immunol. 149, 2513-2517, 1992.
188. Emlen, W., Niebur, J., and Kadera, R., Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152, 3685-3692, 1994.
189. Savill, J., Fadok, V., Henson, P., and Haslett, C., Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14, 131-136, 1993.
190. Narkates, A. J., and Volanakis, J. E., C-reactive protein binding specificities: Artificial and natural phospholipid bilayers. Ann. N.Y. Acad. Sci. 389, 172-182, 1982.
191. Robey, F. A., Jones, K. D., Tanaka, T., and Liu, T. Y., Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. J. Biol. Chem. 259, 7311-7316, 1984.
192. Du Clos, T. W., Zlock, L. T., and Rubin, R. L., Analysis of the binding of C-reactive protein to histones and chromatin. J. Immunol. 141, 4266-4270, 1988.
193. Du Clos, T. W., C-reactive protein reacts with the Ul small ribonucleoprotein. J. Immunol. 143, 2553-2559, 1989.
194. Yung, R. L., and Richardson, B. C., Drug-induced lupus. Rheum. Dis. Clin. 20, 61-86, 1994.
195. Richarson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., and Johnson, M., Evidence for impaired T cell DNA meth-ylation in systemic lupus erythematosus. Arthritis Rheum. 33, 1665-1673, 1990.
196. Rubin, R. L., and Curnutte, J. T., Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro. J. Clin. Invest. 83, 1336-1343, 1989.
197. Jiang, X., Khursigara, G., and Rubin, R. L., Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 266, 810-813, 1994.
198. Mamula, M. J., Fatenejad, S., and Craft, J., B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152, 1453-1461, 1994.